摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,4-dimethyl-3,5-dioxacycloheptanone | 141509-42-4

中文名称
——
中文别名
——
英文名称
4,4-dimethyl-3,5-dioxacycloheptanone
英文别名
2,2-dimethyl-[1,3]dioxepan-5-one;2,2-Dimethyl-1,3-dioxepan-5-one
4,4-dimethyl-3,5-dioxacycloheptanone化学式
CAS
141509-42-4
化学式
C7H12O3
mdl
——
分子量
144.17
InChiKey
CMBZJDYCDJAHJV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    4,4-dimethyl-3,5-dioxacycloheptanone 反应 2.0h, 生成 (5S)-8-((Ξ)-2,2-dimethyl-[1,3]dioxepan-5-ylidene)-3c,4c-dihydroxy-3t-methyl-(5rN)-1-oxa-6,9-diaza-spiro[4.5]decane-7,10-dione
    参考文献:
    名称:
    Structure, absolute configuration, and total synthesis of an acid-catalyzed rearrangement product of bicyclomycin
    摘要:
    DOI:
    10.1021/ja00489a057
  • 作为产物:
    描述:
    4,4-二甲基-3,5,8-三氧杂双环[5,1,0]辛烷 在 lithium aluminium tetrahydride 、 重铬酸吡啶三氟乙酸吡啶 作用下, 以 乙醚二氯甲烷 为溶剂, 反应 48.0h, 生成 4,4-dimethyl-3,5-dioxacycloheptanone
    参考文献:
    名称:
    Comparative studies on the reactivity of 4-methylene-1-oxa-6,9-diazaspiro[4.5]decane-7,10-dione, 1-acetyl-3-hydroxy-3-vinyl-2,5-piperazinedione, and bicyclomycin. Examination of a key structural element necessary for bicyclomycin-mediated transformations
    摘要:
    Two select mimics, 4-methylene-1-oxa-6,9-diazaspiro[4.5]decane-7,10-dione (8) and 1-acetyl-3-hydroxy-3-vinyl-2, 5-piperazinedione (7) of the structurally novel antibiotic, bicyclomycin (1), have been prepared. Comparison of the chemical reactivity of 7 versus 1 both in the presence and absence of added nucleophiles at various "pH" values has provided important new information concerning the role of key structural elements present in bicyclomycin. The product profiles determined for 7 indicated that modification of the terminal double bond proceeded through an alpha,beta-unsaturated ring imine intermediate (i.e., 43). Correspondingly, activation of the exo-methylene group in bicyclomycin is believed to occur through initial hemiaminal bond scission to give a ring-opened alpha,beta-unsaturated carbonyl species (i.e., 2). Functionalization of the terminal double bond in 7 has been shown to proceed under milder conditions than that required for 1. These results demonstrated that incorporation of the exo-methylene group within the O(2)-C(3)-C(4)-C(5) bridge in 1 required that the terminal double bond activation pathway proceed by an alternative, energetically more-demanding pathway than that observed for 7. Ramifications of the decreased reactivity noted for 1 are to allow other functional groups (i.e., the C(1)-triol moiety) in the antibiotic to have important catalytic roles in the drug modification processes and to permit thiolate species (the proposed biological targets?) to effectively compete with other nucleophiles for 2.
    DOI:
    10.1021/jo00039a028
点击查看最新优质反应信息

文献信息

  • Comparative studies on the reactivity of 4-methylene-1-oxa-6,9-diazaspiro[4.5]decane-7,10-dione, 1-acetyl-3-hydroxy-3-vinyl-2,5-piperazinedione, and bicyclomycin. Examination of a key structural element necessary for bicyclomycin-mediated transformations
    作者:Yeong Soo Oh、Harold Kohn
    DOI:10.1021/jo00039a028
    日期:1992.6
    Two select mimics, 4-methylene-1-oxa-6,9-diazaspiro[4.5]decane-7,10-dione (8) and 1-acetyl-3-hydroxy-3-vinyl-2, 5-piperazinedione (7) of the structurally novel antibiotic, bicyclomycin (1), have been prepared. Comparison of the chemical reactivity of 7 versus 1 both in the presence and absence of added nucleophiles at various "pH" values has provided important new information concerning the role of key structural elements present in bicyclomycin. The product profiles determined for 7 indicated that modification of the terminal double bond proceeded through an alpha,beta-unsaturated ring imine intermediate (i.e., 43). Correspondingly, activation of the exo-methylene group in bicyclomycin is believed to occur through initial hemiaminal bond scission to give a ring-opened alpha,beta-unsaturated carbonyl species (i.e., 2). Functionalization of the terminal double bond in 7 has been shown to proceed under milder conditions than that required for 1. These results demonstrated that incorporation of the exo-methylene group within the O(2)-C(3)-C(4)-C(5) bridge in 1 required that the terminal double bond activation pathway proceed by an alternative, energetically more-demanding pathway than that observed for 7. Ramifications of the decreased reactivity noted for 1 are to allow other functional groups (i.e., the C(1)-triol moiety) in the antibiotic to have important catalytic roles in the drug modification processes and to permit thiolate species (the proposed biological targets?) to effectively compete with other nucleophiles for 2.
  • Structure, absolute configuration, and total synthesis of an acid-catalyzed rearrangement product of bicyclomycin
    作者:Hans Maag、John F. Blount、David L. Coffen、Thomas V. Steppe、Frederick Wong
    DOI:10.1021/ja00489a057
    日期:1978.10
查看更多

同类化合物

绿木霉菌素 甲基2,3-脱水-4,6-O-亚苄基-Alpha-D-吡喃糖苷 甲基 2,3-脱水-4,6-亚苄基-ALPHA-D-吡喃甘露糖苷 替达霉素B 替达霉素A 普罗孕酮 戊二酰-2-(羟甲基)蒽并醌 反式-4-环己烯-1,2-二羰基二氯 二氧杂环庚烷 乙基(1R,7S,8r)-3,5-二氧杂双环[5.1.0]辛烷-8-羧酸酯 三乙基二胺 alpha-高-3-脱氧-3,3-二甲基-2,4-二氧杂-25-羟基维他命D3 8,8-二氯-4-乙基-3,5-二氧杂双环[5.1.0]辛烷 7,12-二氧杂螺[5.6]十二烷-10-基甲醇 7,12-二氧杂螺(5.6)十二烷 7,12-二氧杂螺(5,6)十二烷-3-酮 6-[(1E,3E,5E)-6-[(1S,2S,3R,5R,6R)-2,8-二羟基-1,3,5,6-四甲基-4,7-二氧杂双环[3.2.1]辛烷-3-基]己-1,3,5-三烯基]-4-甲氧基-5-甲基吡喃-2-酮 5-甲氧基-7,12-二氧杂螺[5.6]十二烷 5-溴-7,12-二氧杂螺[5.6]十二烷 5-氟-5,7,7-三(三氟甲基)-6-[2,2,2-三氟-1-(三氟甲基)乙亚基]-1,4-二氧杂环庚烷 5,5,6,6-四氟-1,3-二氧杂环庚烷 4-苯基-3,5,8-三氧杂双环[5.1.0]辛烷 4,5-环氧-2-甲氧基-6-甲基-四氢-吡喃-3-醇 4,4-二甲基-3,5,8-三氧杂双环[5,1,0]辛烷 4,4-[(3,20-二氧代孕甾-4-烯-14,17-二基)二氧基]丁酸 3’,5’-脱水胸苷 3-(2-甲基-2-丙基)-7,12-二氧杂螺[5.6]十二烷 3,7,9-三氧杂三环[4.2.1.02,4]壬烷-5-醇 3,7,10-三氧杂三环[4.3.1.02,4]癸烷 3,6-二氧杂-1-环庚醇 3,4-环氧-4-甲基四氢吡喃 2-亚甲基-1,3-二氧烷 2,5-邻亚甲基-d-甘露醇 1-羟基-3,6-二氧杂双环[3.2.1]辛烷-2-酮 1-甲基-4,7-二氧杂双环[4.1.0]庚烷 1-[3-(1,3-二氧杂环庚烷)苯基]-环丙胺 1-(3,5-脱水-2-脱氧-Β-D-苏-戊呋喃糖基)胸腺嘧啶 1,6:2,3-二酐-β-D-吡喃甘露糖 1,5:3,4-二去氢-2-脱氧戊糖醇 1,5:2,3-二脱水-4,6-O-亚苄基-D-蒜糖醇 1,5:2,3-二脱水-4,6-O-[(R)-苯基亚甲基]-D-蒜糖醇 1,5-二氧杂环庚烷-2-酮 1,4-二氧杂环庚烷-6-酮 1,3:2,5:4,6-三-o-亚甲基-D-甘露糖醇 1,3-二氧杂草 1,3-二噁庚环-5-醇,2,2-二甲基-6-(1,4,7,10-四氮杂环十二碳-1-基)- 1,2:3,4-二环氧环戊烷 (5R)-2,2-二甲基-1,3-二氧杂环庚烷-5-甲醛 (1R,2R)-2-[(1aS,8aS)-4beta-(3-呋喃基)-八氢-4abeta-甲基-8-亚甲基-2-氧代环氧乙烷并[d][2]苯并吡喃-7alpha-基]-2,6,6-三甲基-5-氧代-3-环己烯-1-乙酸甲酯 (1S,2S,4S,5S)-1-azido-2-hydroxymethyl-4-(thymin-1-yl)-3,6-dioxabicyclo[3.2.0]heptane